abstract |
There is provided compounds of formula (I), wherein R1, R2, X2, X4 and X5to X8 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation. |